针对G-四重复作为一种新的战略,用于开发抗生素,以对抗高病毒性耐药黄金葡萄球菌
Maria Sultan1, Maria Razzaq1, Joohyun Lee1
1Department of Precision Medicine, Graduate School of Basic Medical Science, Institute for Antimicrobial Resistance Research and Therapeutics, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
Journal of biomedical science
|February 5, 2025
概括
通过向细菌基因中的G-四重复合体,N-甲基介质氨酸IX (NMM) 显示出强大的广泛抗菌活性. 这种新型抗生素方法有效打击耐药细菌,为感染治疗提供了一个有前途的新途径.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 基因组学就是基因组学.
背景情况:
- 多药耐药 (MDR) 细菌病原体的出现需要开发新的抗生素.
- 有限的抗生素标阻碍了像黄金葡萄球菌株 (Staphylococcus aureus) 等菌株引起的感染的治疗.
- G-四重复 (G4) 结合联体被探索为一种新的策略,以下调重要的细菌基因.
研究的目的:
- 为了选G4结合联体对抗MDR黄金葡萄球菌的抗生素特性.
- 确定有前途的配体的体外和体内抗菌活性和作用机制.
- 确定新的抗生素点和抗击细菌感染的药物.
主要方法:
- 查G4结合对黄金葡萄球菌的检测 USA300.00.
- 在体外和体外抗菌活性的确定.
- 微生物,感染,显微镜和生物物理化学技术的应用,以阐明作用机制.
- 全基因组生物信息学分析,以识别细菌基因组中的G4动机.
- 物理化学评估 (UV-Vis,CD,NMR) 来确认目标相互作用.
- 在体内报告者和体内转录/翻译试验.
主要成果:
- N-甲基美索波菲林IX (NMM) 显示出针对金黄色葡萄球菌USA300的显著抗菌活性,最小抑制度 (MIC) 为5μM.
- NMM针对mraz的促进体中的G4基因,mraz是细胞分裂和细胞壁合成 (dcw) 基因集群的关键调节者.
- 证实NMM与mraz G4结构相互作用,导致dcw基因表达的抑制,并影响细菌细胞分裂和细胞壁合成.
- 实验室和体内研究表明,NMM具有广泛的抗葛兰阳性和葛兰阴性细菌活性.
- 与已知抗生素相比,NMM在细胞和动物模型 (RAW264.7细胞,Galleria mellonella) 中表现出优异的抗生素活性,没有观察到细胞毒性.
结论:
- 鉴定出N-甲基美索波菲林IX (NMM) 是一种强效的,广泛的抗菌剂.
- 作用机制涉及针对mraz促进体中的g4动机,破坏重要的细菌过程.
- 这项研究强调了G4结合配体作为新型抗生素对抗耐药细菌的一种有前途的类别.
相关概念视频
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Antibiotic Selection
52.2K
Overview
52.2K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


